Evaluation of the Clinical Relevance of Body Composition Parameters in Patients With Cancer Metastatic to the Liver Treated With Hepatic Arterial Infusion Chemotherapy

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

(2010) S. Antoun et al.   ANNALS OF ONCOLOGY

A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver

(2010) Apostolia M. Tsimberidou et al.   CANCER

Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer

(2009) B. H.L. Tan et al.   CLINICAL CANCER RESEARCH

Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment

(2009) C. M.M. Prado et al.   CLINICAL CANCER RESEARCH

Dietary factors and cancer chemoprevention: An overview of obesity-related malignancies

(2009) A Ray et al.   Journal of Postgraduate Medicine

A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care

(2008) Marina Mourtzakis et al.   Applied Physiology Nutrition and Metabolism

Cachexia: A new definition

(2008) William J. Evans et al.   CLINICAL NUTRITION

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

(2008) Andrew G Renehan et al.   LANCET

Excess baggage: sarcopenia, obesity, and cancer outcomes

(2008) Ronenn Roubenoff   LANCET ONCOLOGY

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

(2008) Carla MM Prado et al.   LANCET ONCOLOGY